PPI and H2 Receptor Antagonist Use and Risk of Liver Cancer PPI and H2 Receptor Antagonist Use and Risk of Liver Cancer
Do PPIs and H2 receptor antagonists contribute to the risk of primary liver cancer?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Gastroenterology | Health | Liver | Proton Pump Inhibitors PPIs | Urology & Nephrology